Omnicell, Inc. - Common Stock (NQ:OMCL)

36.48 -0.40 (-1.08%)

Delayed Quote Updated: 10:52 AM EDT, Oct 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Omnicell, Inc. - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Omnicell to Release First Quarter 2023 Financial Results on May 2, 2023

April 12, 2023

From Omnicell, Inc.

Via Business Wire

Analyst Expectations for Omnicell's Future ↗

March 01, 2023

Via Benzinga

Omnicell Announces Fiscal Year and Fourth Quarter 2022 Results

February 28, 2023

From Omnicell, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For February 27, 2023 ↗

February 27, 2023

Via Benzinga

6 Analysts Have This to Say About Omnicell ↗

January 24, 2023

Via Benzinga

Why Shares of Omnicell Dropped 33.6% This Week ↗

November 04, 2022

The healthcare medication management company released lowered guidance.

Via The Motley Fool

Earnings Scheduled For February 28, 2023 ↗

February 28, 2023

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report earnings for its fourth quarter.

Via Benzinga

Earnings Preview For Omnicell ↗

February 27, 2023

Via Benzinga

Where Omnicell Stands With Analysts ↗

November 03, 2022

Omnicell (NASDAQ:OMCL) has observed the following analyst ratings within the last quarter:

Via Benzinga

What 4 Analyst Ratings Have To Say About Omnicell ↗

September 09, 2022

Within the last quarter, Omnicell (NASDAQ:OMCL) has observed the following analyst ratings:

Via Benzinga

CORRECTING and REPLACING Omnicell to Release Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023

February 16, 2023

From Omnicell, Inc.

Via Business Wire

Amazon To Rally Over 28%? Here Are 10 Other Analyst Forecasts For Tuesday ↗

January 24, 2023

Citigroup raised the price target for AT&T Inc. (NYSE: T) from $20 to $22. Citigroup analyst Michael Rollins maintained a Buy rating. AT&T shares fell 1% to $18.91 in pre-market trading.

Via Benzinga

Omnicell to Present at the 41st Annual J.P. Morgan Healthcare Conference

January 05, 2023

From Omnicell, Inc.

Via Business Wire

Omnicell to Showcase Advanced Services Designed to Deliver Enhanced Medication Management Outcomes at ASHP Midyear 2022

December 05, 2022

From Omnicell, Inc.

Via Business Wire

Stocks That Hit 52-Week Lows On Tuesday ↗

December 20, 2022

On Tuesday, 298 companies achieved new lows for the year.

Via Benzinga

Omnicell to Present at the Piper Sandler 34th Annual Healthcare Conference

November 23, 2022

From Omnicell, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For November 3, 2022 ↗

November 03, 2022

Upgrades

Via Benzinga

9 Analysts Have This to Say About Omnicell ↗

November 03, 2022

Over the past 3 months, 9 analysts have published their opinion on Omnicell (NASDAQ:OMCL) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...

Via Benzinga

Rogers, Airbnb, Herbalife And Some Other Big Stocks Moving Lower On Wednesday ↗

November 02, 2022

U.S. stocks traded lower, with the Nasdaq Composite dropping more than 100 points on Wednesday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Why Tupperware Brands Shares Dipped Around 42%; Here Are 89 Biggest Movers From Yesterday ↗

November 03, 2022

Gainers Starry Group Holdings, Inc. (NYSE: STRY) rose 55.6% to close at $0.28 on Wednesday after reporting Q3 results.

Via Benzinga

Why Benefitfocus Shares Are Trading Higher By Around 48%? Here Are 64 Stocks Moving In Wednesday's Mid-Day Session ↗

November 02, 2022

Gainers Starry Group Holdings, Inc. (NYSE: STRY) gained 56% to $0.2808 after reporting Q3 results.

Via Benzinga

Omnicell: Q3 Earnings Insights ↗

November 02, 2022

Omnicell (NASDAQ:OMCL) reported its Q3 earnings results on Wednesday, November 2, 2022 at 08:00 AM. Here's what investors need to know about the announcement. Earnings Omnicell beat estimated earnings...

Via Benzinga

Omnicell Announces Financial Results for Third Quarter 2022

November 02, 2022

From Omnicell, Inc.

Via Business Wire

Omnicell to Release Third Quarter 2022 Financial Results on November 2, 2022

October 13, 2022

From Omnicell, Inc.

Via Business Wire

Omnicell Launches Specialty Pharmacy Services to Support Optimized Outpatient Medication Management and Drive Clinical and Business Outcomes for Health Systems

October 11, 2022

From Omnicell, Inc.

Via Business Wire

Spero Therapeutics To Rally Around 240%? Plus This Analyst Slashes PT On Salesforce ↗

September 23, 2022

Evercore ISI Group raised the price target on Spero Therapeutics, Inc. (NASDAQ: SPRO) from $2 to $8. Evercore ISI Group analyst Josh Schimmer also upgraded the stock from In-Line to Outperform. Spero...

Via Benzinga

Morgan Stanley To Rally Over 10%? Here Are 5 Other Price Target Changes For Wednesday ↗

September 21, 2022

Credit Suisse raised the price target on Morgan Stanley (NYSE: MS) from $95 to $97. Credit Suisse analyst Susan Roth Katzke maintained the stock with an Outperform rating. Morgan Stanley shares rose...

Via Benzinga

Omnicell Highlights Differentiated Strategy and Unique Business Model at 2022 Investor Day

September 20, 2022

From Omnicell, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For September 16, 2022 ↗

September 16, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022 ↗

September 09, 2022

Upgrades

Via Benzinga

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.